Who asks India to check if cough syrup is extracted

• Toxic cough syrup associated with deaths of 17 children under five years.
• Tests show that Indian pharmacists have failed to test rules.
• Gujarat’s state finds shortages in two other cough syrup manufacturers.

The Indian authorities informed the public to avoid two more cough syrup brands on Wednesday after the deaths of 17 children under the age of five associated with a toxic ingredient and addressed questions about whether any infected syrup was exported.

Children died in India last month after eating coughing medicine containing toxic diaitylene in quantities of almost 500 times the permitted limit, officials say. Deaths were all associated with Coldrif, banned after a test confirmed the presence of the chemical on October 2.

Respifresh and Relife syrups also contain diathylene glycol, according to a public alarm from Gujarat and other states on Wednesday that described it as “toxic chemical that can cause severe poisoning, including kidney deficiency, neurological deficiency, neurological deficiency and neurological deficiency.

The World Health Organization (which) said Reuters He sought clarification from New Delhi on whether a cough syrup associated with deaths has exported to other countries.

Advised against cough, cold drugs for children

Coldrif, made by Sresan’s pharmaceutical manufacturer, was sold only locally, according to a government document observed by Reuters. Gujarat officials said the other two syrups were sold to other Indian states, but are not mentioned in exports. Companies and drug officials did not answer questions about whether the other two syrups were exported.

PE stated that he would evaluate the need for alerting world medical products in Coldrif syrup as soon as he receives official confirmation from the Indian authorities.

The UN Health Organization continues to advise the use of cough and cold drugs for children.

Earlier, the country’s drug controller Rajeev Raghuvanshi said the regulator had found serious delays in the factories that the drugs were under control showing that they had failed to test any batch of medicinal ingredients as needed.

On the advice of October 7 and published on a government website, Raghuvanshi did not name companies or the number of those found to have retreated, but said the inspections were carried out in businesses whose drugs had been found earlier that they were under standard quality.

By law, Indian pharmacists should try every lot of raw materials and the finished product. Exports of cough syrups required another layer of testing in laboratories that have been challenged by the government by 2023 after the deaths of more than 140 children in Gambia, Uzbekistan and Cameroon associated with Indian syrups.

Abandoned factory

Reuters was unable to get in touch with Sresan G Ranganathan chief, whose office and factory in the southern Tamil Nantu state were closed. Police are investigating the murder company, syrup sales have been banned and central authorities have recommended the cancellation of Sresan’s production permit.

Reuters saw drug inspectors paste a notice on Tuesday on the walls of the Sresan facility in the Kancheepuram industrial area, Tamil Nadu, who requested details, including the way the drug was produced and where its ingredients came.

There was no gift to answer the employees. Behind the installation, the bottles of syrup and burnt drugs turn to the ground, with a sharp chemical odor that remains in the air.

The Ministry of Health said Sunday authorities conducted inspections in 19 other production units in six states.

Two of the inspected companies were the manufacturer of Relife Shape Pharma and the manufacturer Respifresh Rednex Pharmaceuticals, based in Gujarat, a key pharmaceutical hub. State authorities said on Tuesday that coughing samples produced by companies had been found to be “not standardized quality”.

State and Federal Inspectors recognized unspecified deficiencies and ordered immediate interruption throughout production and distribution. Shape and Rednex did not respond to comments for comments.

Ethylene or diathylenoglycol toxins were found in Indian cough syrups that killed children in Gambia, Uzbekistan and Cameroon by 2022 and 12 children in India in 2019, destroying the image of the third largest drug -based country.

India’s pharmaceutical industry, which exceeds the size of the US and China only, is estimated at $ 50 billion. More than half its value comes from exports.

India provides 40% of general drugs used in the US and over 90% of all drugs in many African nations.